Hamilton Thorne Ltd.
HTL
Clasificación en acciones
#16956
Hamilton Thorne Ltd. is a leading enterprise focused on the development,... Hamilton Thorne Ltd. is a leading enterprise focused on the development, manufacturing, and global distribution of specialized instrumentation, laboratory equipment, consumables, software, and a range of services. The company's offerings are primarily directed towards the fields of assisted reproductive technologies (ART), scientific research, and cell biology. Their product line includes sophisticated laser and imaging systems designed for biological studies, custom-built workstations, incubators, and essential equipment for IVF laboratories. They also produce critical medical devices for reproductive medicine, such as ovum pickup needles and catheters, and provide comprehensive in-vitro diagnostic (IVD) systems, from initial research and design to sales, installation, and ongoing servicing. Environmental control solutions like the Cell-Tek Microscope Chamber, which meticulously manages temperature, airflow, and humidity, are also part of their extensive catalog, alongside laminar flow workstations. Furthermore, Hamilton Thorne pioneers software innovations, including AI-powered CASA (Computer-Assisted Sperm Analysis) for image analysis. The company's service array covers thorough laboratory testing, notably endotoxin analysis and specialized sperm assays (like the Sperm Motility Index and Sperm Penetration), as well as the provision of fresh and cryopreserved mouse embryos, coupled with technician training and proficiency testing programs. Marketed under respected brand names such as Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, MICROPTIC, Gynétics, and Embryotech, their products and services reach a diverse global customer base—including fertility clinics, hospitals, pharmaceutical and biotechnology companies, academic institutions, and various commercial research entities—via a direct sales presence in countries like the United States, Germany, France, Australia, Denmark, Belgium, Spain, and the United Kingdom, complemented by an extensive distributor network covering around 100 nations. Hamilton Thorne Ltd. maintains its headquarters in Beverly, Massachusetts.
Precio por acción
$1.64
Última sincronización: 2024-12-02
Capitalización bursátil
$253.46M
Cambio (1 día)
2.87%
Cambio (1 año)
3.40%
País
US
Comercio Hamilton Thorne Ltd. (HTL)
Categoría
Healthcare
Ratio P/E de Hamilton Thorne Ltd. (HTL)
Ratio P/E al October 2026 TTM: -387.83
Según los últimos informes financieros y el precio de las acciones de Hamilton Thorne Ltd., el P/E actual (TTM) de la empresa es -387.83. Al final de 2022, la empresa tenía un P/E de 91.33.
Historial del ratio P/E de Hamilton Thorne Ltd. desde 2008 hasta 2026
Relación P/E al final de cada año
| Año | Ratio P/E | Cambiar |
|---|---|---|
| 2026 (TTM) | -387.83 | 59.24% |
| 2023 | -243.55 | -366.69% |
| 2022 | 91.33 | -4.30% |
| 2021 | 95.43 | -39.39% |
| 2020 | 157.45 | 26.56% |
| 2019 | 124.41 | 371.95% |
| 2018 | 26.36 | 161.23% |
| 2017 | 10.09 | -72.34% |
| 2016 | 36.48 | 279.55% |
| 2015 | 9.61 | -56.10% |
| 2014 | 21.90 | 14.40% |
| 2013 | 19.14 | -996.31% |
| 2012 | -2.14 | 72.31% |
| 2011 | -1.24 | 28.28% |
| 2010 | -0.97 | 40.85% |
| 2009 | -0.69 | 565.28% |
| 2008 | -0.10 | 0.00% |
Relación P/E para empresas similares o competidores
| Empresa | P/E Ratio | Diferencia del P/E Ratio | País |
|---|---|---|---|
| 47.48 | -112.24% |
US
|
|
| 27.43 | -107.07% |
FR
|
|
| - | - |
JP
|
|
| 56.89 | -114.67% |
US
|
|
| - | - |
CH
|
¿Cómo leer un P/E ratio?
El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.
Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.
Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.